Retinal detachment following focal laser to ruptured retinal artery macro aneurysm

Rom J Ophthalmol. 2021 Jan-Mar;65(1):70-72. doi: 10.22336/rjo.2021.13.

Abstract

A 53-year-old lady presented with inferior retinal detachment (RD) following focal laser for retinal artery macroaneurysm (RAM). She underwent focal laser with intravitreal gas injection elsewhere; however, no retinal break was localized on the examination. The patient was taken up for vitreoretinal surgery. Intraoperatively, it was noted that the retinal detachment was not extending to the retinal periphery and primary retinal break was not localized even during the scleral depression. Under high magnification, using a macular lens, a slit-like retinal break was noted at the area of previous focal laser. Focal laser for RAM probably caused this retinal break leading to RD. The clinician needs to be aware that during focal laser of ruptured RAM, haemorrhage may preclude the view of retinal structures leading to inadvertent use of excessive laser energy. Retinal breaks may form at the site of laser due to coagulative necrosis. During surgical management of RD in such cases, the area of focal laser should be thoroughly examined under high magnification to avoid missed breaks.

Keywords: focal laser; retinal arterial macroaneurysm; retinal detachment.

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage
  • Bevacizumab / administration & dosage*
  • Female
  • Fluorescein Angiography / methods
  • Fundus Oculi
  • Humans
  • Intravitreal Injections
  • Laser Coagulation / adverse effects*
  • Middle Aged
  • Postoperative Complications*
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • Retinal Arterial Macroaneurysm / complications*
  • Retinal Arterial Macroaneurysm / diagnosis
  • Retinal Arterial Macroaneurysm / surgery
  • Retinal Artery / diagnostic imaging*
  • Retinal Detachment / diagnosis
  • Retinal Detachment / drug therapy
  • Retinal Detachment / etiology*
  • Visual Acuity*

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab
  • Receptors, Vascular Endothelial Growth Factor